News >

Novel Frontline Approaches Induce Deep, Durable Responses in Multiple Myeloma

Jessica Hergert
Published: Tuesday, Sep 03, 2019

Michael A. Rosenzweig, MD, MS, assistant clinical professor of Hematology and Hematopoietic Cell Transplantation and hematologist/oncologist at City of Hope

Michael A. Rosenzweig, MD, MS
Utilizing the oncology standard that "more is better," frontline treatment options for patients with multiple myeloma are expanding to include more novel agents and different combinations in order to obtain deeper responses, explained Michael A. Rosenzweig, MD, MS.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Practice Connections™: From Diagnosis to Emerging Immunotherapeutic Options: Understanding the Burden and Risks in Peanut AllergySep 28, 20191.0
Enduring CME activity from the School of Breast Oncology®: 2018 Mid-Year Video UpdateSep 28, 20192.0
Publication Bottom Border
Border Publication